Abstract |
The antitumor activity of pectinesterase inhibitor (PEI), a group of cationic polypeptides, from jelly fig (Ficus awkeotsang Makino) achene was first examined as a treatment for leukemia in this study. PEI displayed strong growth inhibition against human leukemic U937 cells via induction of apoptosis in a dose- and time-dependent manner. At a level of 50 microg/mL, PEI inhibited 90% of cell growth, and the concentration of PEI required to induce 50% of cell viability (LC50) was about 180 microg/mL. Meanwhile, cell cycle arrest at G2/M phase was observed when cells were incubated with 100 microg PEI/mL for 24 h. PEI displayed a dose-dependent influence on mitochondria transmembrane potential (MTP, delta psi m) of cells when detected by a flow cytometry. MTP of more than 50% cells was reduced when cells were incubated with PEI at levels higher than 50 microg PEI/mL for 24 h. In addition, PEI upregulated caspase-3 activity. Taken together, PEI potently inhibited the proliferation of human leukemic U937 cells via cell cycle arrest and apoptosis in association with MTP reduction and caspase-3 activation, respectively, and showed therapy potential for U937 cells.
|
Authors | Jia-Huei Chang, Yuh-Tai Wang, Hung-Min Chang |
Journal | Annals of the New York Academy of Sciences
(Ann N Y Acad Sci)
Vol. 1042
Pg. 506-15
(May 2005)
ISSN: 0077-8923 [Print] United States |
PMID | 15965097
(Publication Type: Journal Article)
|
Chemical References |
- Annexin A5
- Enzyme Inhibitors
- Carboxylic Ester Hydrolases
- pectinesterase
- CASP3 protein, human
- Caspase 3
- Caspases
|
Topics |
- Annexin A5
(metabolism)
- Apoptosis
(drug effects)
- Carboxylic Ester Hydrolases
(antagonists & inhibitors, metabolism)
- Caspase 3
- Caspases
(metabolism)
- Enzyme Inhibitors
(pharmacology)
- Ficus
(chemistry)
- Fruit
(chemistry)
- Humans
- Leukemia
(metabolism, pathology)
- Mitochondria
(drug effects, metabolism)
- U937 Cells
|